Maxx Pharmaceuticals Private Limited
About Maxx Pharmaceuticals Private Limited
Data last updated:
Maxx Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2014PTC256572. Its GSTIN is 27AAJCM3168P1ZR (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandesh Pandurang Vaidya and Pritee Yogesh Khandave.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 216 – A 2nd Floor Soham Plaza Manpada Bus Stop Chitalsar G.B. Road, Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2020, the company reported a revenue of ₹22.85 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹11,886 (net margin -0.5%) and EBITDA of ₹6.92 Lakh (EBITDA margin 30.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address216 – A 2nd Floor Soham Plaza Manpada Bus Stop Chitalsar G.B. Road, Thane, Maharashtra, India – 400607
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Maxx Pharmaceuticals Private Limited FY 2025 filings available
Maxx Pharmaceuticals Private Limited reported revenue of ₹22.85 Lakh (up 953% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Maxx Pharmaceuticals Private Limited
Revenue rose 953% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Maxx Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹22.85 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.92 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹11,886 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maxx Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxx Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Maxx Pharmaceuticals Private Limited
Maxx Pharmaceuticals Private Limited is audited by DILIP THAKKAR & ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DILIP THAKKAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maxx Pharmaceuticals Private Limited
Maxx Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandesh Pandurang Vaidya | Director | 25 Jul 2014 | 12 Years 2 Months | Current |
| Pritee Yogesh Khandave Also directs: Crystal Homes Buildpro LLP | Director | 25 Jul 2014 | 12 Years 2 Months | Current |
Ownership and Shareholding of Maxx Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxx Pharmaceuticals Private Limited
Maxx Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxx Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Maxx Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxx Pharmaceuticals Private Limited
Maxx Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Pritee Yogesh Khandave was appointed as Director on 25 Jul 2014.
Credit Ratings, Litigation & Regulatory Alerts for Maxx Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxx Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxx Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxx Pharmaceuticals Private Limited
Maxx Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCM3168P1ZR | Maharashtra | Active | 08 Jul 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxx Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxx Pharmaceuticals Private Limited
Maxx Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 July 2014 (12+ years old) and is registered under CIN U24110MH2014PTC256572.
Maxx Pharmaceuticals reported revenue of ₹22.85 Lakh for FY 2020 (up 953% YoY).
Maxx Pharmaceuticals has 2 current directors:
- Sandesh Pandurang Vaidya - Director
- Pritee Yogesh Khandave - Director
Maxx Pharmaceuticals reported a net loss of ₹11,886 (net margin -0.5%) and EBITDA of ₹6.92 Lakh (EBITDA margin 30.3%) for FY 2020, as per its filed financial statements.
The GSTIN of Maxx Pharmaceuticals is 27AAJCM3168P1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Maxx Pharmaceuticals is U24110MH2014PTC256572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxx Pharmaceuticals was incorporated on 25 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Pritee Yogesh Khandave was appointed as Director on 25 Jul 2014. Sandesh Pandurang Vaidya was appointed as Director on 25 Jul 2014.
The registered office of Maxx Pharmaceuticals is at 216 – A 2nd Floor Soham Plaza Manpada Bus Stop Chitalsar G.B. Road, Thane, Maharashtra, India – 400607.
Maxx Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.